chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Provider ordered MCV4 vaccine for patient, but the lot number that was entered into the patient record was for PCV13 vaccine.  It did not come to the attention of the RN Manager until several months later when the DOH asked for the lot number, and it was found that the lot number was for PCV13 and not MCV4.
pt recvd vax; PAR noted arm swelling; to MD w/ swelling, warm & redness & pain from shoulder to elbow; tx w/ dph & motrin for comfort;
Information has been received from a physician concerning a 13 year old female who on 12-JAN-2007 was vaccinated with her first dose of HPV rL1 6 11 16 18 VLP vaccine (yeast) 0.5 ml intramuscularly.  The patient fainted when she got outside in the parking lot of the physician's office (also reported as within 10 minutes). The patient was brought back into the physician's office and "let rest for a while".  The physician checked the patient's blood pressure (no details provided). The physician noted that the patient is "fine now".  Additional information has been requested.
7 months pregnant. Began to experience facial paralysis, left side two days after injection. Went to ER, diagnosed with Bell's Palsy.
Fevers, sudden onset respiratory distress and emesis with asymmetric generalized seizures.
I had a large lump/swelling under my left armpit towards the lower end/upper side.  When I cupped my hand on top if it, it filled up my hand (so, it was about the size of a lemon) and was very tender.  It lasted 4-5 days, then went away.   When I was feeling sick about a month ago, it swelled up again, but only to about half of that size.  That area is still tender sometimes.  I did not go into the dr because I had heard weird things could happen with the vaccine.
Patient received a booster dose of the PEDIATRIC Pfizer, when should have received ADULT dosage;  No adverse advents occured
vesicular rash that was pink, red, bumpy and painful on fingers on both hands after first and second vaccine; Vesicular rash that was pink, red, bumpy and painful on fingers on both hands after first and second vaccine; This is a spontaneous report from a contactable Other HCP. A 33-year-old female patient received bnt162b2 (COVID-19 MRNA VACCINE BIONTECH) via an unspecified route of administration, the first dose on an unspecified date, then the second dose on 29Jan2021 at a single dose for covid-19 immunisation. There were no medical history and concomitant medications. After the first vaccine, she got a vesicular rash that was pink, red, bumpy, and painful on her fingers. The same thing happened, but worse after the second dose on day 3. The reporter did not know if it was the same fingers both times. She did know it was a few fingers on both hands. The events were reported as medically significant. No other investigation assessment done. The outcome of the events was recovering.  Information on the lot/batch number has been requested.; Sender's Comments: Based on temporal association and profile of the product, the contributory role of the suspect product BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) to reported Rash vesicular and  pain in extremity cannot totally be excluded.
First he focused more,To point where it got bad; became more obsessive; became more aggressive; Hoarding everything; started behaving worse; Irreverably change his mental state; life is worse; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DISTURBANCE IN ATTENTION (First he focused more,To point where it got bad), OBSESSIVE THOUGHTS (became more obsessive), AGGRESSION (became more aggressive), COMPULSIVE HOARDING (Hoarding everything) and ABNORMAL BEHAVIOUR (started behaving worse) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Autistic disorder (autistic).   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DISTURBANCE IN ATTENTION (First he focused more,To point where it got bad), OBSESSIVE THOUGHTS (became more obsessive), AGGRESSION (became more aggressive), COMPULSIVE HOARDING (Hoarding everything), ABNORMAL BEHAVIOUR (started behaving worse), MENTAL DISORDER (Irreverably change his mental state) and IMPAIRED QUALITY OF LIFE (life is worse). At the time of the report, DISTURBANCE IN ATTENTION (First he focused more,To point where it got bad), OBSESSIVE THOUGHTS (became more obsessive), AGGRESSION (became more aggressive), COMPULSIVE HOARDING (Hoarding everything), ABNORMAL BEHAVIOUR (started behaving worse), MENTAL DISORDER (Irreverably change his mental state) and IMPAIRED QUALITY OF LIFE (life is worse) outcome was unknown.            No concomitant medications were reported.  It was reported that patient refused taking medicines.  No treatment medications were reported.
chills; headache; This is a spontaneous report from a contactable consumer. A 37-years-old female patient received second dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number unknown) via unspecified route on 05Mar2021 as SINGLE DOSE for COVID-19 immunisation. The patient previously took first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number unknown) via unspecified route on an unspecified date as SINGLE DOSE for COVID-19 immunisation. Medical history included ongoing rheumatoid arthritis. The patient's concomitant medications were not reported.06Mar2021, The patient experienced chills and headache. The outcome of events was unknown.  No follow up attempts are possible. No further information is expected.
Patient awoke with a high degree of dizziness (feeling as though the room was spinning), nauseous, and soaking wet (as in a hot flash). For the next two days he could hardly get out of bed due to dizziness and then feeling nausea if he tried to get up. He had no fever. On the third day he was up for awhile, but the dizziness continued to be intense for at least 7 days. I am writing this 2 weeks after the vaccine was received, and he still reports dizziness when he leans over quickly.
Fatigue 4/21/2015; chills, joint pain, burning nerve pain along waistline, headache, hot tender swelling at injection site 4/22 & 4/23/2015, with increasing swelling 4/23/2015 entire upper arm length; Dr. visit 4/24/2015 recommended cool compresses & Benadryl; applied compresses & self-administered L-Lysine 500 MG BOD & ibuprofen as needed for pain from 4/24-4/27/2015. As of 4/28/2015 only small red bump at injection site, but some nerve discomfort & muscle weakness in left arm & hand.
From initial information received on May 25 2005 from a health care facility regarding an adverse event, it was reported that an 18 year old male patient received his first dose of Menactra, lot number U1575AA, administered intramuscularly on May 13 2005 in preparation for college. The site of administration was not reported. The following day, on May 14 2005, the patient complained of fatigue, headache, body aches, a stiff neck and felt as if he was in a fog. The patient was seen by a physician on May 17 2005. Reportedly, he recovered from all of the events.
Left deltoid at area of injection red, swollen, painful by evening on day of injection, pain in left shoulder, upper arm, down to elbow. Hard to lift shoulder. Next day injection site hard, hot, swollen. Progressed to nausea, chills, glands in neck swollen. Treated with ice & ibuprofen. At office visit 3/1/13, still had 13 x 15 cm very faint erythema, slightly warm, indurated, and mildly tender left upper arm but injection site clear.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable Consumer. The reporter is the patient. A 70-year-old female patient received BNT162b2 (BNT162B2), on 26Sep2021 as dose 3 (booster), single (Lot number: fc3184) at the age of 70 years, in left arm for covid-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "known allergies: sulfa" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Patient received Paxlovid from 03Aug2022 to 08Aug2022 for COVID 19 Treatment.
About 20 minutes after the vaccine was administered I felt a wave of nausea and felt like I was going to vomit; then I felt dizzy; About 20 minutes after the vaccine was administered I felt a wave of nausea and felt like I was going to vomit; diarrhea; This is a spontaneous report from a contactable consumer (patient)  A 77-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL324) on 14Jan2021 at 10:00 at single dose via an unspecified route of administration  on arm left for COVID-19 immunization. Relevant medical history included GERD, disc disease, meningioma, diverticulitis, panic attack and allergy to Macrodantin, Levaquin and Bactrim. Concomitant medications included metoprolol, atorvastatin, omeprazole and alprazolam. On 14Jan2021 about 20 minutes after the vaccine was administered patient felt a wave of nausea and felt like she was going to vomit, then she felt dizzy. Patient waited another 30 minutes before driving home hoping it would subside. Patient informed she have been nauseated, dizzy and had diarrhea on and off for 9 days. She didn't called her doctor yet or notified anyone at the site hoping it would pass, as she knew that nausea was one of the side effects. The patient was not treated for the events. At the time of the reporting the patient had not yet recovered from the event.
Second dose of Moderna given 7 days to early. It was administered on 2/10/23 but was due 2/17/2023. No adverse effects to patient.
Begin as a hard lump that was red and very sore.  The distance around was the size of a peach, it was very raised and hard underneath.  The next morning (10/8/10) it was the distance around was the size of a baseball, the swelling came down some, it was warm and bright red.  10/9/10 am swelling is down, and is now looking reddish/blue like a bruise.  Not as sore but feels tight and itchy.
This patient was admitted to the emergency room, was COVID-19 positive even though the patient was immunized.  The patient was saturating in the mid 90s on room air. Dyspnea on exertion. Congestive heart failure, systolic with exacerbation. Consultation was made for Pulmonary and Cardiology. His medications were adjusted. Discharged to home.
Painful, red, swelling at injection site (left deltoid) warm to touch - spreading down left arm. Placed on antibiotic instructed to return if no improvement or worsens. Instructed to come in Friday to see nurse for assessment.
Same day adverse advent started w a severe headache followed by days of dizziness headache and most concerning loss of normal vision. Symptoms lasted over 6 days.
Patient experienced inflammation with systemic response after second dose of shingrix. Given acetaminophen and methylprednisolone and symptoms resolved
Initial report was received on 11 April 2014 from a non health care professional. A 61 year-old female patient with a history of diabetes, hypertension, an allergy to Cymbalta and was not acutely ill at time of vaccination had received on 08 April 2014 a left deltoid dose of ADACEL, lot number C4543AA (route of administration not reported) and two days later on 10 April 2014, experienced redness, swelling and warmth at injection site. Redness measured 4 x 3 inches. Doctor felt it was cellulitis. Treatment included Doxycycline. The vaccine was administered using a 5/8 inch needle. The patient's last tetanus shot was over 10 years ago. No further information was available at the time of the report. Outcome was unknown. Documents held by sender: none.
admitted from Assisted Living Facility on 9/10 through 9/14 due to pancreatic issues. coincidentally found to be COVID (+) without any symptoms.
Uncontrollable chills, high temp around 102 F, and racing heart, and some slight difficulty breathing.
Patient reported tingling of her right hand right after she got her vaccine.  Patient stated that the same happened when she got the first dose.  At 94:43 am she stated she is feeling better and tingling is going away.  She wants to go home.  At 9:47 am patient stated she is going home, she is feeling ok now.
Diarrhoea; This spontaneous report was received from a registered nurse (RN) refers to a 11-week-old male patient.  The patient did not have any pertinent medical history, past drugs and allergies. The concomitant medications included multivitamin and fluconazole.  On 27-SEP-2019, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ), via oral route (lot number R029818 and expiration date: 09-JUL-2020) for prevention of rota-virus (prophylaxis). On 02-OCT-2019, the patient experienced diarrhoea. On 03-OCT-2019, the patient was taken to the emergency room. The nurse reported that the patient was unable to submit a stool sample to be analyzed. Treatment was not given for the event. The patient underwent unspecified blood work. It was also reported that the patient's brother experienced same event. At the time of report, the event of diarrhoea was recovering. The causality assessment was not reported.  This is one of two reports received from same reporter.; Sender's Comments:  US-009507513-1910USA007401:
AFTER HAVING FIRST DOSE OF PFIZER COVID-19 VACCINE ON 7/27/2021 HAD FATIGUE, MUSCLE ACHES WHICH INCREASED ON 7/29/2021 EXPERIENCING PALPITATIONS, WEAKNESS, MUSCLE ACHES, SHAKINESS, MUSCLE TWITCHING.   ON 7/29/2021 ARRIVED TO MEDICAL CENTER ER WITH ACUTE RESPIRATORY FAILURE WITH HYPOXIA, PALPITATIONS, GENERALIZED WEAKNESS, UNABLE TO AMBULATE.  WAS PLACED ON OXYGEN, ADMITTED TO THE FLOOR AND MONITORED OVERNIGHT.
Two Hib containing vaccine were given to patient on the same day. Vaxelis (DTaP+Hib+IPV+HepB) and PedvaxHib were administered on 02/12/2022 by on-call MA. Vaxelis was given in left thigh and Hib in right thigh.
1st: 24hr after the shot. Cold chills, Body aches, fatigue and headache for approx. 24hr 2nd: approx. 7hr after Cold chills, feverish, Body aches, fatigue, headache and  up set stomach for approx. 30 hrs.
Blister formed near the site of injection, within a week another blister formed about 1/2 inch of affected skin. Patient went to urgent care on 9/26 and started 10 days of BACTRIM for cellulitis. Patient has healing scar as of today.
Complained of stomach, became light headed, pale and diaphoretic,and weak.  Squad responded, child may or may not have passed out. Right arm site - no reddness or irritation.  Recovered without any intervention by squad. Advised to see pediatrician/appointment made for 3:15pm.
6"x5" erythematous reaction, warm, non-indurated, non-tender left arm where DTaP given.
Got vaccine, ended up with shingles in her eyes/ Suspected vaccination failure; Shingles in her eyes; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and ophthalmic herpes zoster (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure and ophthalmic herpes zoster were unknown.   The reporter considered the vaccination failure and ophthalmic herpes zoster to be related to Shingles vaccine.     Additional Information: GSK receipt date: 15-Aug-2022 Reporter's Comments: The patient's friend reported the case via interactive digital media. The reporter stated not to get this vaccine. The patient got Shingles vaccine and ended up with shingles in her eyes. She was almost because of this vaccine. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary immunization, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
patient felt dizzy as soon as johnson covid vaccine was administered, then she fainted and had seizures which lasted about 30 seconds, regained consciousness was confused, then she was fine for like 2 minutes, then she fainted again and seizures for 30 seconds, regained consciousness and was fine.
fever 102-104 x 5 days w/lethargy;seen 11OCT95 by MD tonsilitis/URI; placed on Cefzil 250mg x 10days
killing millions already with their covid vaccine including my wife; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID.  An elderly (age reported as "60-99") female (also reported as male) patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death), outcome "fatal", described as "killing millions already with their covid vaccine including my wife". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed.  Additional information: The reporter stated that Pfizer is not very trustworthy with more people killed by their COVID vaccine including the reporter's wife than any previous new vaccine.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: killing millions already with their covid vaccine including my wife
Since I had the shot I been experiencing warming in my chest, numbing on my face (left side) and difficulty breathing. I went to the hospital to be checked and nothing found but I?m still feeling the same way since receiving the shot
On 2/20/2018 patient seen in office with cough, runny nose and bumps on legs and face. No fever.  Diagnosed with vaccine induced varicella. Had at least 50 lesions
Client given immunizations and reported feeling fine.  RN went to print copy of records and when RN returned, client was laying on the floor.  Client reported that when she stood to retrieve her purse, she felt lightheaded and fell to the ground.  She denied hitting her head or any injury.  Client given water and monitored until returned to baseline.
This report describes the occurrence of joint pain in a 51 year old female who received Lyme disease vaccine recombinant injection for prophylaxis. This report was initially received from the vaccinee's husband and has not been verified by a physician or other healthcare professional. A legal complaint was subsequently received from an attorney. The following information was initially received from the patient's husband. No allergies were reported. The vaccinee had Lyme disease approximately two years ago. The vaccinee has hypothyroidism and takes Synthroid. In March 1999, April 1999, and April 2000, the vaccinee received her first, second, and third doses of LYMErix, respectively. Early in April 2000, she experienced high fever, flu-like symptoms, and severe joint pain. The vaccinee was seen by an orthopedist and a neurologist. Two MRI's have been done which reveal no degenerative changes or arthritis. The legal complaint received 9/15/04 stated that the patient (now age 55) experienced memory loss, poor concentration, joint pain, disorientation, fatigue, unsteady gait, encephalopathy, neuropathy, and demyelination on MRI treated with Avonex. Time to onset and outcome were not provided. Per follow up report received 04/13/2005:  This is a legal case, and additional follow up is unavailable.
Fussy, congestion, cough, decreased appetite, temp 104 degree F lasting 3 days.  Also diagnosed with acute Otitis Media on day 3.  Treated with AUGMENTIN and ROCEPHIN.
Chronic arm pain and inflammation since vaccination.    Prior to vaccine I had no history of tendinitis or arthritis in my left side.  Now post Covid vaccine I am dealing with symptoms like RA
My entire upper left  arm and shoulder/neck radiate with pain. I am unable to rotate or flex my arm without severe and radiant pain. My arm is weak and cannot raise, lift or rotate it above the elbow.  Very difficult to maintain sleep with a throbbing arm. I have been taking Alleve and it helps but the pain is still there just milder. Muscles are not sore but something is aching deep in bone/joints. I went to the Kinesiologist who told me the rotor cuff is the issue. He did an pressure point "adjustment" and the pain subsided for a day or two and now I'm back to being in pain during any level of movement again.  I believe that my injection was given too high in my shoulder and caused SIRVA. I even took a picture of where the injection site was given.  If needed I can provide it to you.
Patient with history of COPD. She was brought in the ED by EMS on 2/23/23 for sneezing, shortness of breath, cough, fever, and myalgias. A COVID PCR test was done in the ED which resulted positive. She required supplemental O2 to maintain normal O2 saturations. Ultimately she was admitted 2/23/23 - 2/27/23. Dexamethasone 6mg daily was started 2/23/23. Discharge diagnoses included acute hypoxic respiratory failure due to COVID-19 infection, among other diagnoses. Patient required supplemental O2 during admission (2 liters) but was eventually weaned to room air.  Of note, the patient has received the primary COVID vaccine series and two boosters.
DIZZY; TINGLY ALL OVER BODY; LITTLE NUMBNESS IN TONGUE; NAUSEA; This spontaneous report received from a patient concerned a 40 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included in remission breast cancer, and other pre-existing medical conditions included no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, and expiry: UNKNOWN) dose was not reported, administered on 03-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 04-JUN-2021, the subject experienced dizzy. On 04-JUN-2021, the subject experienced tingly all over body. On 04-JUN-2021, the subject experienced little numbness in tongue. On 04-JUN-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dizzy, tingly all over body, little numbness in tongue, and nausea. This report was non-serious.